QUANTITATION OF THE GLYCATION INTERMEDIATE 3-DEOXYGLUCOSONE BY OXIDATION WITH RABBIT LIVER OXOALDEHYDE DEHYDROGENASE TO 2-KETO-3-DEOXYGLUCONIC ACID FOLLOWED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引:11
作者
FUJII, E
IWASE, H
ISHIIKARAKASA, I
YAJIMA, Y
HOTTA, K
机构
[1] KITASATO UNIV,SCH MED,DEPT INTERNAL MED,SAGAMIHARA,KANAGAWA 228,JAPAN
[2] KITASATO UNIV,SCH MED,DEPT BIOCHEM,SAGAMIHARA,KANAGAWA 228,JAPAN
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1994年 / 660卷 / 02期
关键词
D O I
10.1016/0378-4347(94)00313-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and sensitive method for the detection of 3-deoxyglucosone was developed using oxidation with crude oxoaldehyde dehydrogenase to 2-keto-3-deoxygluconic acid followed by high-performance liquid chromatography (HPLC). Oxoaldehyde dehydrogenase was prepared from rabbit liver and partially characterized. 2-Keto-3-deoxygluconic acid produced from 3-deoxyglucosone by oxoaldehyde dehydrogenase was derivatized with 1,2-diamino-4,5-methylenedioxybenzene , and the fluorescent products were detected and quantitated by HPLC using a solvent containing berate. In the presence of berate, 2-keto-3-deoxygluconic acid was completely separated from N-acetylneuraminic acid. The detection limit of 3-deoxyglucosone was 2.5 pmol/injection (10 mu l) at a signal-to-noise ratio of 3. This method was used to confirm the inhibitory effect of aminoguanidine on glycation.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 21 条
[1]   AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING [J].
BROWNLEE, M ;
VLASSARA, H ;
KOONEY, A ;
ULRICH, P ;
CERAMI, A .
SCIENCE, 1986, 232 (4758) :1629-1632
[2]  
CERAMI A, 1987, SCI AM, V256, P82
[3]   1,2-DIAMINO-4,5-ETHYLENEDIOXYBENZENE AS A HIGHLY SENSITIVE FLUOROGENIC REAGENT FOR AROMATIC-ALDEHYDES [J].
CHAO, WF ;
KAI, M ;
ISHIDA, J ;
OHKURA, Y ;
HARA, S ;
YAMAGUCHI, M .
ANALYTICA CHIMICA ACTA, 1988, 215 (1-2) :259-266
[4]   AMINOGUANIDINE AMELIORATES ALBUMINURIA IN DIABETIC HYPERTENSIVE RATS [J].
EDELSTEIN, D ;
BROWNLEE, M .
DIABETOLOGIA, 1992, 35 (01) :96-97
[5]   AMINOGUANIDINE TREATMENT INHIBITS THE DEVELOPMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY [J].
HAMMES, HP ;
MARTIN, S ;
FEDERLIN, K ;
GEISEN, K ;
BROWNLEE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11555-11558
[6]   DETERMINATION OF MONO-O-ACETYLATED N-ACETYLNEURAMINIC ACIDS IN HUMAN AND RAT SERA BY FLUOROMETRIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
HARA, S ;
YAMAGUCHI, M ;
TAKEMORI, Y ;
FURUHATA, K ;
OGURA, H ;
NAKAMURA, M .
ANALYTICAL BIOCHEMISTRY, 1989, 179 (01) :162-166
[7]  
HATA F, 1988, IGAKUNOAYUMI, V147, P571
[8]   FRACTIONATION OF DNS-GLYCOPEPTIDES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
IWASE, H ;
LI, SC ;
LI, YT .
JOURNAL OF CHROMATOGRAPHY, 1983, 267 (01) :238-241
[9]   ANALYSIS OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE ACTIVITY BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY ON A SILICA-BASED CHEMICALLY BONDED OCTADECYL COLUMN [J].
IWASE, H ;
MORINAGA, T ;
LI, YT ;
LI, SC .
ANALYTICAL BIOCHEMISTRY, 1981, 113 (01) :93-95
[10]  
IWASE H, 1992, CRC HDB ENDOGLYCOSID, P41